DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: BYR-123634 |   Others

Historical data: 2017 - 2023

Forecast period: 2025 - 2031

Quantitative units: Revenue in USD million and CAGR from 2025 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Detection of infectious disease biomarkers Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET

7.1 GLOBAL DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)

8.1 GLOBAL DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

8.2 GLOBAL DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

9.1 GLOBAL DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

9.2 GLOBAL DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

10.1 GLOBAL DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)

10.2 GLOBAL DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)

11.1 NORTH AMERICA DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

11.2 NORTH AMERICA DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

11.3 NORTH AMERICA DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

11.4 NORTH AMERICA DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

11.5 NORTH AMERICA DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

11.6 NORTH AMERICA DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

12.1 EUROPE DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

12.2 EUROPE DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

12.3 EUROPE DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

12.4 EUROPE DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

12.5 EUROPE DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

12.6 EUROPE DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

13.1 ASIA PACIFIC DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

13.2 ASIA PACIFIC DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

13.3 ASIA PACIFIC DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

13.4 ASIA PACIFIC DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

13.5 ASIA PACIFIC DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

13.6 ASIA PACIFIC DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

14.1 LATIN AMERICA DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>

14.2 LATIN AMERICA DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

14.3 LATIN AMERICA DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

14.4 LATIN AMERICA DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

14.5 LATIN AMERICA DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

14.6 LATIN AMERICA DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA DETECTION OF INFECTIOUS DISEASE BIOMARKERS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>

16.1 PerkinElmer

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Quest Diagnostics Incorporated

16.3 Becton

16.4 Thermo Fisher Scientific

16.5 Hologic

16.6 Qiagen

16.7 Abbott Laboratories

16.8 Abacus Diagnostica

16.9 Bio-Rad Laboratories

16.10 Danaher

16.11 ALPCO

16.12 bioMérieux SA

16.13 Dickinson and Company

16.14 F Hoffmann-La Roche

16.15 Agilent Technologies

16.16 Siemens Healthineers

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

Major Types Covered
IHC
PCR
ISH
NGS
ELISA or EIA
other

Major Downstream Industry Covered
hospitals and clinics
other
Academic research institutions
Diagnostic Center

Companies

PerkinElmer
Quest Diagnostics Incorporated
Becton
Thermo Fisher Scientific
Hologic
Qiagen
Abbott Laboratories
Abacus Diagnostica
Bio-Rad Laboratories
Danaher
ALPCO
bioMérieux SA
Dickinson and Company
F Hoffmann-La Roche
Agilent Technologies
Siemens Healthineers

Single User License  : 3900$
Corporate License    : 7800$
Enquiry Before Buying
Request For Customization
Speak To Analyst

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE

    • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY

    • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH

    • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING

    • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.